Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

US Doctor Exposed to Ebola Virus Admitted to NIH

September 29, 2014 10:23 am | News | Comments

An American doctor who was exposed to the Ebola virus while volunteering in Sierra Leone was admitted Sunday to a hospital at the National Institutes of Health near the nation's capital.           

TOPICS:

Omaha Hospital Workers Fired Over Ebola Privacy

September 29, 2014 10:21 am | by MARGERY A. BECK, Associated Press | News | Comments

The Nebraska hospital that treated an American aid worker infected with Ebola has fired two workers accused of violating the man's privacy by looking at his medical file.              

TOPICS:

Daiichi Sankyo to Acquire Ambit Biosciences

September 29, 2014 10:15 am | News | Comments

Daiichi Sankyo Company and Ambit Biosciences, jointly announced today that they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer followed by a merger with a subsidiary of Daiichi Sankyo, or approximately $315 million on a fully diluted basis.

TOPICS:
Advertisement

Chiltern Acquires Pacific Clinical Research

September 29, 2014 10:10 am | News | Comments

Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens in particular Chiltern's oncology and anti-infective offerings.

TOPICS:

FDA Approves Revised Indication for Allergan's OZURDEX®

September 29, 2014 10:06 am | News | Comments

Allergan announced today that the U.S. Food and Drug Administration (FDA) has approved OZURDEX® (dexamethasone intravitreal implant) 0.7 mg, a sustained-release biodegradable steroid implant, for the treatment of diabetic macular edema (DME).  

TOPICS:

Amag Pharma to Spend $675M on Lumara Health

September 29, 2014 10:03 am | News | Comments

The Waltham, Massachusetts, company said Monday it will spend $600 million in cash and another $75 million in stock on the privately held Lumara, which makes Makena, a treatment designed to reduce the risk of premature birth.     

TOPICS:

Exelixis Shares Soar on Skin Cancer Study Results

September 29, 2014 9:54 am | News | Comments

Shares of Exelixis jumped Monday before markets opened and after the drugmaker said its treatment for a deadly form of skin cancer fared better than another drug in a late-stage clinical study.          

TOPICS:

Alimera, pSivida say FDA Clears Eye Implant

September 26, 2014 5:45 pm | by The Associated Press | News | Comments

Alimera Sciences and pSivida said Friday the FDA approved their eye disease implant Iluvien. Iluvien is an implant delivered by injection that is intended to treat diabetic macular edema, a condition that can cause blurred vision and blindness. 

TOPICS:
Advertisement

M&A Update: Abbott, CFR, Pfizer, InnoPharma

September 26, 2014 11:07 am | News | Comments

Pfizer announced that it has completed its acquisition of pharmaceutical development company, InnoPharma, Inc., and Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American-branded generics pharmaceutical presence.

TOPICS:

Protein "Map" Could Lead To New Cancer Drugs

September 26, 2014 10:54 am | News | Comments

Chemists have gained fresh insights into how a disease-causing enzyme makes changes to proteins and how it can be stopped. They hope their findings will help to design drugs that could target the enzyme, known as NMT, and potentially lead to new treatments for cancer and inflammatory conditions.

TOPICS:

AbbVie Gets Approval For Humira

September 26, 2014 10:48 am | News | Comments

The FDA cleared Humira as a treatment for moderate to severe Crohn's disease in children ages six and older when those children haven't been helped by other treatments, AbbVie said. Humira can be administered at home, unlike similar drugs used to treat the condition.

TOPICS:

Report Shows Discrepancies In Access to Cancer Drugs

September 26, 2014 10:41 am | News | Comments

Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show. Researchers say the results demonstrate the need for better collaboration between doctors and health authorities on an international scale, to ensure patients have access to the best treatments.

TOPICS:

Akorn Breaks Ground on $18 Million Expansion

September 26, 2014 10:24 am | News | Comments

Akorn, Inc. has broken ground on a project that will add 40,000 square feet to its plant. The company recently bought a neighboring property to accommodate the expansion, which includes remodeling and modernizing equipment as part of an $18 million effort to increase production.

TOPICS:

WHO: Ebola Vaccine On The Way

September 26, 2014 10:12 am | News | Comments

The World Health Organization says there should be thousands of doses of experimental Ebola vaccines available in the coming months and they could eventually be given to health care workers and other people who have had contact with the sick.

TOPICS:

Pacira Pharmaceuticals Shares Drop As FDA Warns On Misleading Ads

September 25, 2014 9:34 am | by Associated Press | News | Comments

Pacira Pharmaceuticals Inc. said Thursday that it received a warning letter from regulators about marketing for an injectable drug that numbs post-surgical pain that the letter says is misleading.                                        

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading